SlideShare a Scribd company logo
1 of 21
Pancreatic Neoplasms in Children: A Review of
Institutional Experience and Literature
0
Presented by: Sebastian Hurtado
Bishop O’Dowd High School, Senior
Mentor: Dr. Wendy Su, M.D.
CHORI Summer Symposium
August 15, 2014
Introduction: What We Will Cover
1
-Background information regarding pancreatic
malignancies in children
-Summer research project objectives
-Methods of review and analysis
-Results of studies, analysis of trends and data,
collection of images
-Future Directions
-Acknowledgements
-Questions
Background Information
2
The Pancreas
-Glandular organ
-Digestive and endocrine systems
-Histology of pancreatic tissue: islets
(endocrine/hormonal role), ducts,
and acini (exocrine/digestive role)
-Malignant pancreatic tumors
are extremely rare tumors in
the pediatric population.
The pancreatic cancer
incidence is 0.2% of all
pediatric malignancies
Head Tail
Body
Objectives of My Project
3
To give the public a better understanding of these rare neoplasms, we aim to:
-Identify and characterize pancreatic neoplasms in children to
provide more readily accessible information for the general medical
community so that timely referral and better patient/family
education can be provided
-Identify and characterize:
-Tumor types
-Presentation and diagnosis
-Treatment
-Prognostic factors and outcome
Methods
4
-Review the databases of CHO
-Analyze literature on global experiences
-Assess the national Kid’s Inpatient Database
(KID) from the Healthcare Cost and Utilization Project
-Create spreadsheets to synthesize collected data in an organized
form
-Use descriptive statistics such as tables and graphs to represent
statistical trends
-Examine pathology slides of pancreatic neoplastic tissue to better
understand the histology of the disease
Results-Types of Pancreatic Tumors found in
children
5
The Big Four
-Pancreatoblastoma
-Solid Pseudopapillary Tumor
-Pancreatic Neuroendocrine Tumor
-Pancreatic Ductal
Adenocarcinoma
1) Pancreatoblastoma
6
-Derived from
blastoma/pluripotential stem cells
-One of the most common in children
-Mostly occur in early childhood
-Commonly seen in Africans, Asians, and other non-Caucasian races
-Account for 1%-3% of pancreatic tumors in children overall
-Common in teenage females
2) Solid Pseudopapillary Tumor
Squamoid Corpuscle
Pseudopapillae
H&E
Staining
used
3) Pancreatic Neuroendocrine Tumor
7
-Common in teenage population
-Associated with MEN 1 syndrome and tuberous
sclerosis complex
-Origins in Langerhan islet cells
Acini
Islet
PNT
Immunohistochemical staining used: The tumor is positive for Synaptophysin,
which is a neuroendocrine cell marker. The islets of Langerhans are also positive
4) Pancreatic Ductal Adenocarcinoma
-Arise from mutations in ductal cells of pancreas (try to for normal ducts)
-Very rare in children
Normal Pancreatic Duct
Results-Presentation and Diagnosis
-Detected using CT scans, MRI scans, or
ultrasonography
-Common symptoms include palpable masses,
abdominal pain, jaundice, weight loss, and
nausea
-Common treatments include
resection of the tumor via
pancreaticoduodenectomy or partial/distal
pancreatectomy
-Much better prognosis in children than adults, in
which the majority (80%-99%) do not live past 6
months to 1 year after initial diagnosis
9
Results-Literature Review
10
1) The Memorial-Sloan Kettering Cancer Center Experience,
New York, USA
2) The Italian TREP Project Experience, Italy (nationwide)
3) Kyungpook National University Medical Center Experience,
Korea
4) Bambino Gesu Children’s Hospital Experience, Rome, Italy
5) General Hospital of Vienna, University of Vienna Medical
School Experience, Vienna, Austria
6) Hospital for Sick Children, Toronto, Ontario, Canada
7) Children’s Hospital Research Center Oakland, Oakland, USA
The Memorial-Sloan Kettering Experience
11
Statistics from retrospective review from 1967 to Present
-17 patients
-2 lost to follow up, 12/15 alive without disease
PB
29%
SPT
41%
PNT
12%
PADC
6%
Others
12%
Distribution of Types
Palpable mass
19%
Jaundice
15%
Weight Loss
23%
Anorexia
14%
Malaise
10%
Nausea
19%
Common Symptoms
PB=5
SPT=7
PNT=2
PADC=1
Others=2 (peripheral
neuroectodernal tumors)
The Italian TREP Project Experience
12
Statistics on Retrospective Study from Tumori Rari in Eta Pediatrica (TREP) from January
2000-July 2009
-Out of 488 patients with rare tumors, 21 patients with pancreatic tumors identified
0
2
4
6
8
10
12
14
Males Females
Gender and Type Distribution
PB PADC PNT SPT
Conclusions from Memorial Sloan-Kettering
Experience
13
-PB more common in males (4/5), SPT more common in females (5/7)
-Positive prognosis=12/15 alive (80% survival rate)
-PB and SPT most common
-PB more common in males=good prognosis, all alive but one (toxic
death)
-SPT more common in teenage females
-Good prognosis for SPT resection: 11/12 alive in 1st remission, 1 relapse
-Pancreatic tumors very rare: 4% of all rare tumors registered
Conclusions from Italian TREP Experience
Demographics of Pancreatic Neoplasm Patients at CHRCO
14
*Age during treatment; **Metastases/Chemotherapy/other treatment; ***Intermittent lower abdominal pain; ****post-2003, in 2003: AWD
CHRCO Conclusions
15
-Majority of SPTs are present in teen females (3/4)
-7/9 alive today=excellent prognosis
-Tuberous sclerosis, anemia, or previous abdominal issues are risk factors (warnings)
-Size does not seem to be indicator of specific type
-Most commonly occurring in tail (in females and PNTs)
-SPT most common type
All of these conclusions… …help primary care physicians with parent
consultation/consolation and expand understanding!
45%
11%
33%
11%
Type Distribution in Oakland
SPT PB PNT PADC
16
0
10
20
30
40
50
60
70
Alive Without Evidence of Disease Died of Disease Lost to Follow Up
Overall Patient Outcomes
Outcomes
1 Relapse
63 AWD
6 DOD
4 LTFU
58%
15%
14%
8%
5%
Overall Type Distribution
SPT PB PNT PADC Others
SPT=42
PB=11
PNT=10
PADC=6
Others=4
Overall Results
Overall Conclusions
-Four main types of pancreatic tumors in children: pancreatoblastoma, solid
pseudopapillary tumor, pancreatic neuroendocrine tumor, pancreatic ductal
adenocarcinoma
-Overall prognosis is much better, with 86% survival rate in our project,
compared to adults with a 1-10% survival rate
-Surgical resection via PT or PDD provided curative treatment
-Specific trends/clues can help determine the type and grade of pancreatic
tumors
17
Future Directions
18
-Portion of project not completed:
-Analysis of KID national database from Healthcare Cost and
Utilization Project
-To continue the project, we could:
-Collect more specific experiences from institutions
worldwide to minimize bias of the representation of only
certain tumor types/institutions
-In the future, we hope to create a presentable database for
surgery conventions
Presented by: Sebastian Hurtado
Mentor: Dr. Wendy Su, M.D.
Pediatric Surgical Associates of East Bay
Acknowledgements:
A special thank you to . . .
END
-Wendy Su, M.D.
-The Doris Duke Charitable Foundation
-Ellen Fung, PhD RD CCD
-Ward Hagar, M.D.
-Elaine Cham, M.D. CHRCO Pathologist
-CHORI Summer Student Program Faculty and Staff
Answers to Possible Questions
 Hypotheses for better prognosis in children than adults:
-increased check-ups/visits in children, cancer caught at
lower stage
-risk factors from lifestyle choices in adults (i.e. smoking,
alcohol consumption) vs. genetics
-biology of the tumor for each age group (SPT vs.
pancreatic adenocarcinoma): “better” and “worse” types
-types of tumors are different
-overall “youth factor”: younger and more intact
immune system
20

More Related Content

What's hot

Caris Centers of Excellence Virtual Molecular Tumor Board Fox Chase - Jan 26,...
Caris Centers of Excellence Virtual Molecular Tumor Board Fox Chase - Jan 26,...Caris Centers of Excellence Virtual Molecular Tumor Board Fox Chase - Jan 26,...
Caris Centers of Excellence Virtual Molecular Tumor Board Fox Chase - Jan 26,...Caris Life Sciences
 
Caris Centers of Excellence Virtual Molecular Tumor Board - Sep 28, 2015 - We...
Caris Centers of Excellence Virtual Molecular Tumor Board - Sep 28, 2015 - We...Caris Centers of Excellence Virtual Molecular Tumor Board - Sep 28, 2015 - We...
Caris Centers of Excellence Virtual Molecular Tumor Board - Sep 28, 2015 - We...Caris Life Sciences
 
Aurelia asco 20121
Aurelia asco 20121Aurelia asco 20121
Aurelia asco 20121lefein
 
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!National Ovarian Cancer Coalition
 
Caris Centers of Excellence Virtual Molecular Tumor Board - August 12, 2015
Caris Centers of Excellence Virtual Molecular Tumor Board - August 12, 2015Caris Centers of Excellence Virtual Molecular Tumor Board - August 12, 2015
Caris Centers of Excellence Virtual Molecular Tumor Board - August 12, 2015Caris Life Sciences
 
Caris Centers of Excellence Virtual Molecular Tumor Board - June 29, 2015
Caris Centers of Excellence Virtual Molecular Tumor Board - June 29, 2015Caris Centers of Excellence Virtual Molecular Tumor Board - June 29, 2015
Caris Centers of Excellence Virtual Molecular Tumor Board - June 29, 2015Caris Life Sciences
 
Caris Centers of Excellence Virtual Molecular Tumor Board - February 23, 2016...
Caris Centers of Excellence Virtual Molecular Tumor Board - February 23, 2016...Caris Centers of Excellence Virtual Molecular Tumor Board - February 23, 2016...
Caris Centers of Excellence Virtual Molecular Tumor Board - February 23, 2016...Caris Life Sciences
 
Propranolol for treatment of infantile hemangiomas
Propranolol for treatment of infantile hemangiomasPropranolol for treatment of infantile hemangiomas
Propranolol for treatment of infantile hemangiomasmesfin mamuye
 
Cancer screening ppt.
Cancer screening ppt.Cancer screening ppt.
Cancer screening ppt.Gaurav Kumar
 
Dr Ayman Ewies - Prevalence of hyperplasia and cancer in endometrial polyps i...
Dr Ayman Ewies - Prevalence of hyperplasia and cancer in endometrial polyps i...Dr Ayman Ewies - Prevalence of hyperplasia and cancer in endometrial polyps i...
Dr Ayman Ewies - Prevalence of hyperplasia and cancer in endometrial polyps i...AymanEwies
 
3- ca cx ppt final
 3- ca cx ppt final 3- ca cx ppt final
3- ca cx ppt finalBasalama Ali
 
Chapter 2.3 cancer screening
Chapter 2.3 cancer screeningChapter 2.3 cancer screening
Chapter 2.3 cancer screeningNilesh Kucha
 
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...iosrjce
 
Prostate Cancer Testing and Screening
Prostate Cancer Testing and ScreeningProstate Cancer Testing and Screening
Prostate Cancer Testing and ScreeningCatherine Holborn
 
Catch it before it catches you october 2018
Catch it before it catches you october 2018Catch it before it catches you october 2018
Catch it before it catches you october 2018Mary Ondinee Manalo Igot
 
Ca de endometrio guidelines
Ca de endometrio guidelinesCa de endometrio guidelines
Ca de endometrio guidelinesAntolino Rosales
 

What's hot (20)

Caris Centers of Excellence Virtual Molecular Tumor Board Fox Chase - Jan 26,...
Caris Centers of Excellence Virtual Molecular Tumor Board Fox Chase - Jan 26,...Caris Centers of Excellence Virtual Molecular Tumor Board Fox Chase - Jan 26,...
Caris Centers of Excellence Virtual Molecular Tumor Board Fox Chase - Jan 26,...
 
Caris Centers of Excellence Virtual Molecular Tumor Board - Sep 28, 2015 - We...
Caris Centers of Excellence Virtual Molecular Tumor Board - Sep 28, 2015 - We...Caris Centers of Excellence Virtual Molecular Tumor Board - Sep 28, 2015 - We...
Caris Centers of Excellence Virtual Molecular Tumor Board - Sep 28, 2015 - We...
 
Aurelia asco 20121
Aurelia asco 20121Aurelia asco 20121
Aurelia asco 20121
 
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
 
Caris Centers of Excellence Virtual Molecular Tumor Board - August 12, 2015
Caris Centers of Excellence Virtual Molecular Tumor Board - August 12, 2015Caris Centers of Excellence Virtual Molecular Tumor Board - August 12, 2015
Caris Centers of Excellence Virtual Molecular Tumor Board - August 12, 2015
 
Caris Centers of Excellence Virtual Molecular Tumor Board - June 29, 2015
Caris Centers of Excellence Virtual Molecular Tumor Board - June 29, 2015Caris Centers of Excellence Virtual Molecular Tumor Board - June 29, 2015
Caris Centers of Excellence Virtual Molecular Tumor Board - June 29, 2015
 
Caris Centers of Excellence Virtual Molecular Tumor Board - February 23, 2016...
Caris Centers of Excellence Virtual Molecular Tumor Board - February 23, 2016...Caris Centers of Excellence Virtual Molecular Tumor Board - February 23, 2016...
Caris Centers of Excellence Virtual Molecular Tumor Board - February 23, 2016...
 
Propranolol for treatment of infantile hemangiomas
Propranolol for treatment of infantile hemangiomasPropranolol for treatment of infantile hemangiomas
Propranolol for treatment of infantile hemangiomas
 
2014 Ovarian Cancer National Conference: Ovarian Cancer 101
2014 Ovarian Cancer National Conference: Ovarian Cancer 1012014 Ovarian Cancer National Conference: Ovarian Cancer 101
2014 Ovarian Cancer National Conference: Ovarian Cancer 101
 
Cancer screening ppt.
Cancer screening ppt.Cancer screening ppt.
Cancer screening ppt.
 
Dr Ayman Ewies - Prevalence of hyperplasia and cancer in endometrial polyps i...
Dr Ayman Ewies - Prevalence of hyperplasia and cancer in endometrial polyps i...Dr Ayman Ewies - Prevalence of hyperplasia and cancer in endometrial polyps i...
Dr Ayman Ewies - Prevalence of hyperplasia and cancer in endometrial polyps i...
 
3- ca cx ppt final
 3- ca cx ppt final 3- ca cx ppt final
3- ca cx ppt final
 
Chapter 2.3 cancer screening
Chapter 2.3 cancer screeningChapter 2.3 cancer screening
Chapter 2.3 cancer screening
 
UOG Journal Club: Prenatal identification of invasive placentation using ultr...
UOG Journal Club: Prenatal identification of invasive placentation using ultr...UOG Journal Club: Prenatal identification of invasive placentation using ultr...
UOG Journal Club: Prenatal identification of invasive placentation using ultr...
 
PIVOT
PIVOTPIVOT
PIVOT
 
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...
 
Breakout: Side Effects of Cancer Treatment: Robert Morgan MD
Breakout: Side Effects of Cancer Treatment: Robert Morgan MD Breakout: Side Effects of Cancer Treatment: Robert Morgan MD
Breakout: Side Effects of Cancer Treatment: Robert Morgan MD
 
Prostate Cancer Testing and Screening
Prostate Cancer Testing and ScreeningProstate Cancer Testing and Screening
Prostate Cancer Testing and Screening
 
Catch it before it catches you october 2018
Catch it before it catches you october 2018Catch it before it catches you october 2018
Catch it before it catches you october 2018
 
Ca de endometrio guidelines
Ca de endometrio guidelinesCa de endometrio guidelines
Ca de endometrio guidelines
 

Similar to Revised Final HurtadoS-PancreaticNeoplasmsPresentation-2014

Pancreatic Cancer Advances in Treatment Assignment.pdf
Pancreatic Cancer Advances in Treatment Assignment.pdfPancreatic Cancer Advances in Treatment Assignment.pdf
Pancreatic Cancer Advances in Treatment Assignment.pdfbkbk37
 
fap final 2.pptx mmmm......mmmmmmmmmmmmmm
fap final 2.pptx mmmm......mmmmmmmmmmmmmmfap final 2.pptx mmmm......mmmmmmmmmmmmmm
fap final 2.pptx mmmm......mmmmmmmmmmmmmmIbrahemIssacGaied
 
Recent advances in pancreatic pathology
Recent advances in pancreatic pathology Recent advances in pancreatic pathology
Recent advances in pancreatic pathology Appy Akshay Agarwal
 
Virtual Tumor Board: Building Comprehensive Care Plans in Esophagogastric Can...
Virtual Tumor Board: Building Comprehensive Care Plans in Esophagogastric Can...Virtual Tumor Board: Building Comprehensive Care Plans in Esophagogastric Can...
Virtual Tumor Board: Building Comprehensive Care Plans in Esophagogastric Can...i3 Health
 
Cystic pancreatic tumor.dr quiyum
Cystic pancreatic tumor.dr quiyumCystic pancreatic tumor.dr quiyum
Cystic pancreatic tumor.dr quiyumMD Quiyumm
 
Ca pancreas part diagnosis and workup
Ca pancreas part diagnosis and workupCa pancreas part diagnosis and workup
Ca pancreas part diagnosis and workupSatyajeet Rath
 
CES 2016 02 - Gastric cancer
CES 2016 02 - Gastric cancerCES 2016 02 - Gastric cancer
CES 2016 02 - Gastric cancerMauricio Lema
 
Week 6 DiscussionQuestion ARisk management is a matter of id.docx
Week 6 DiscussionQuestion ARisk management is a matter of id.docxWeek 6 DiscussionQuestion ARisk management is a matter of id.docx
Week 6 DiscussionQuestion ARisk management is a matter of id.docxcockekeshia
 
Paeds henoch schonlein purpura guideline
Paeds henoch schonlein purpura guidelinePaeds henoch schonlein purpura guideline
Paeds henoch schonlein purpura guidelineSisorady Kok
 
Carcinoma of unknown primary in a patient
Carcinoma of unknown primary in a patientCarcinoma of unknown primary in a patient
Carcinoma of unknown primary in a patientg9440536269
 
Vorinostat Case Study
Vorinostat Case StudyVorinostat Case Study
Vorinostat Case StudyAshley Jean
 
Multidisciplinary Approach in a Peritoneal Surface Malignancy Program
Multidisciplinary Approach in a Peritoneal Surface Malignancy ProgramMultidisciplinary Approach in a Peritoneal Surface Malignancy Program
Multidisciplinary Approach in a Peritoneal Surface Malignancy ProgramMary Ondinee Manalo Igot
 
Genetic counseling & prenatal diagnosis
Genetic counseling & prenatal diagnosisGenetic counseling & prenatal diagnosis
Genetic counseling & prenatal diagnosisAftab Siddiqui
 
CES2016-02: Gastric cancer
CES2016-02: Gastric cancerCES2016-02: Gastric cancer
CES2016-02: Gastric cancerMauricio Lema
 

Similar to Revised Final HurtadoS-PancreaticNeoplasmsPresentation-2014 (20)

Pancreatic Cancer Advances in Treatment Assignment.pdf
Pancreatic Cancer Advances in Treatment Assignment.pdfPancreatic Cancer Advances in Treatment Assignment.pdf
Pancreatic Cancer Advances in Treatment Assignment.pdf
 
Tgh talk
Tgh talkTgh talk
Tgh talk
 
fap final 2.pptx mmmm......mmmmmmmmmmmmmm
fap final 2.pptx mmmm......mmmmmmmmmmmmmmfap final 2.pptx mmmm......mmmmmmmmmmmmmm
fap final 2.pptx mmmm......mmmmmmmmmmmmmm
 
Recent advances in pancreatic pathology
Recent advances in pancreatic pathology Recent advances in pancreatic pathology
Recent advances in pancreatic pathology
 
Virtual Tumor Board: Building Comprehensive Care Plans in Esophagogastric Can...
Virtual Tumor Board: Building Comprehensive Care Plans in Esophagogastric Can...Virtual Tumor Board: Building Comprehensive Care Plans in Esophagogastric Can...
Virtual Tumor Board: Building Comprehensive Care Plans in Esophagogastric Can...
 
Future of pnd - Eurocat 2011
Future of pnd - Eurocat 2011Future of pnd - Eurocat 2011
Future of pnd - Eurocat 2011
 
Cystic pancreatic tumor.dr quiyum
Cystic pancreatic tumor.dr quiyumCystic pancreatic tumor.dr quiyum
Cystic pancreatic tumor.dr quiyum
 
Cancer of Pancreas
 Cancer of Pancreas Cancer of Pancreas
Cancer of Pancreas
 
Ca pancreas part diagnosis and workup
Ca pancreas part diagnosis and workupCa pancreas part diagnosis and workup
Ca pancreas part diagnosis and workup
 
CES 2016 02 - Gastric cancer
CES 2016 02 - Gastric cancerCES 2016 02 - Gastric cancer
CES 2016 02 - Gastric cancer
 
Week 6 DiscussionQuestion ARisk management is a matter of id.docx
Week 6 DiscussionQuestion ARisk management is a matter of id.docxWeek 6 DiscussionQuestion ARisk management is a matter of id.docx
Week 6 DiscussionQuestion ARisk management is a matter of id.docx
 
Paeds henoch schonlein purpura guideline
Paeds henoch schonlein purpura guidelinePaeds henoch schonlein purpura guideline
Paeds henoch schonlein purpura guideline
 
Carcinoma of unknown primary in a patient
Carcinoma of unknown primary in a patientCarcinoma of unknown primary in a patient
Carcinoma of unknown primary in a patient
 
Vorinostat Case Study
Vorinostat Case StudyVorinostat Case Study
Vorinostat Case Study
 
Multidisciplinary Approach in a Peritoneal Surface Malignancy Program
Multidisciplinary Approach in a Peritoneal Surface Malignancy ProgramMultidisciplinary Approach in a Peritoneal Surface Malignancy Program
Multidisciplinary Approach in a Peritoneal Surface Malignancy Program
 
Thesis
Thesis Thesis
Thesis
 
Genetic counseling & prenatal diagnosis
Genetic counseling & prenatal diagnosisGenetic counseling & prenatal diagnosis
Genetic counseling & prenatal diagnosis
 
Screening what tests when
Screening what tests whenScreening what tests when
Screening what tests when
 
Pancreatic Cancer.pptx
Pancreatic Cancer.pptxPancreatic Cancer.pptx
Pancreatic Cancer.pptx
 
CES2016-02: Gastric cancer
CES2016-02: Gastric cancerCES2016-02: Gastric cancer
CES2016-02: Gastric cancer
 

Revised Final HurtadoS-PancreaticNeoplasmsPresentation-2014

  • 1. Pancreatic Neoplasms in Children: A Review of Institutional Experience and Literature 0 Presented by: Sebastian Hurtado Bishop O’Dowd High School, Senior Mentor: Dr. Wendy Su, M.D. CHORI Summer Symposium August 15, 2014
  • 2. Introduction: What We Will Cover 1 -Background information regarding pancreatic malignancies in children -Summer research project objectives -Methods of review and analysis -Results of studies, analysis of trends and data, collection of images -Future Directions -Acknowledgements -Questions
  • 3. Background Information 2 The Pancreas -Glandular organ -Digestive and endocrine systems -Histology of pancreatic tissue: islets (endocrine/hormonal role), ducts, and acini (exocrine/digestive role) -Malignant pancreatic tumors are extremely rare tumors in the pediatric population. The pancreatic cancer incidence is 0.2% of all pediatric malignancies Head Tail Body
  • 4. Objectives of My Project 3 To give the public a better understanding of these rare neoplasms, we aim to: -Identify and characterize pancreatic neoplasms in children to provide more readily accessible information for the general medical community so that timely referral and better patient/family education can be provided -Identify and characterize: -Tumor types -Presentation and diagnosis -Treatment -Prognostic factors and outcome
  • 5. Methods 4 -Review the databases of CHO -Analyze literature on global experiences -Assess the national Kid’s Inpatient Database (KID) from the Healthcare Cost and Utilization Project -Create spreadsheets to synthesize collected data in an organized form -Use descriptive statistics such as tables and graphs to represent statistical trends -Examine pathology slides of pancreatic neoplastic tissue to better understand the histology of the disease
  • 6. Results-Types of Pancreatic Tumors found in children 5 The Big Four -Pancreatoblastoma -Solid Pseudopapillary Tumor -Pancreatic Neuroendocrine Tumor -Pancreatic Ductal Adenocarcinoma
  • 7. 1) Pancreatoblastoma 6 -Derived from blastoma/pluripotential stem cells -One of the most common in children -Mostly occur in early childhood -Commonly seen in Africans, Asians, and other non-Caucasian races -Account for 1%-3% of pancreatic tumors in children overall -Common in teenage females 2) Solid Pseudopapillary Tumor Squamoid Corpuscle Pseudopapillae H&E Staining used
  • 8. 3) Pancreatic Neuroendocrine Tumor 7 -Common in teenage population -Associated with MEN 1 syndrome and tuberous sclerosis complex -Origins in Langerhan islet cells Acini Islet PNT Immunohistochemical staining used: The tumor is positive for Synaptophysin, which is a neuroendocrine cell marker. The islets of Langerhans are also positive
  • 9. 4) Pancreatic Ductal Adenocarcinoma -Arise from mutations in ductal cells of pancreas (try to for normal ducts) -Very rare in children Normal Pancreatic Duct
  • 10. Results-Presentation and Diagnosis -Detected using CT scans, MRI scans, or ultrasonography -Common symptoms include palpable masses, abdominal pain, jaundice, weight loss, and nausea -Common treatments include resection of the tumor via pancreaticoduodenectomy or partial/distal pancreatectomy -Much better prognosis in children than adults, in which the majority (80%-99%) do not live past 6 months to 1 year after initial diagnosis 9
  • 11. Results-Literature Review 10 1) The Memorial-Sloan Kettering Cancer Center Experience, New York, USA 2) The Italian TREP Project Experience, Italy (nationwide) 3) Kyungpook National University Medical Center Experience, Korea 4) Bambino Gesu Children’s Hospital Experience, Rome, Italy 5) General Hospital of Vienna, University of Vienna Medical School Experience, Vienna, Austria 6) Hospital for Sick Children, Toronto, Ontario, Canada 7) Children’s Hospital Research Center Oakland, Oakland, USA
  • 12. The Memorial-Sloan Kettering Experience 11 Statistics from retrospective review from 1967 to Present -17 patients -2 lost to follow up, 12/15 alive without disease PB 29% SPT 41% PNT 12% PADC 6% Others 12% Distribution of Types Palpable mass 19% Jaundice 15% Weight Loss 23% Anorexia 14% Malaise 10% Nausea 19% Common Symptoms PB=5 SPT=7 PNT=2 PADC=1 Others=2 (peripheral neuroectodernal tumors)
  • 13. The Italian TREP Project Experience 12 Statistics on Retrospective Study from Tumori Rari in Eta Pediatrica (TREP) from January 2000-July 2009 -Out of 488 patients with rare tumors, 21 patients with pancreatic tumors identified 0 2 4 6 8 10 12 14 Males Females Gender and Type Distribution PB PADC PNT SPT
  • 14. Conclusions from Memorial Sloan-Kettering Experience 13 -PB more common in males (4/5), SPT more common in females (5/7) -Positive prognosis=12/15 alive (80% survival rate) -PB and SPT most common -PB more common in males=good prognosis, all alive but one (toxic death) -SPT more common in teenage females -Good prognosis for SPT resection: 11/12 alive in 1st remission, 1 relapse -Pancreatic tumors very rare: 4% of all rare tumors registered Conclusions from Italian TREP Experience
  • 15. Demographics of Pancreatic Neoplasm Patients at CHRCO 14 *Age during treatment; **Metastases/Chemotherapy/other treatment; ***Intermittent lower abdominal pain; ****post-2003, in 2003: AWD
  • 16. CHRCO Conclusions 15 -Majority of SPTs are present in teen females (3/4) -7/9 alive today=excellent prognosis -Tuberous sclerosis, anemia, or previous abdominal issues are risk factors (warnings) -Size does not seem to be indicator of specific type -Most commonly occurring in tail (in females and PNTs) -SPT most common type All of these conclusions… …help primary care physicians with parent consultation/consolation and expand understanding! 45% 11% 33% 11% Type Distribution in Oakland SPT PB PNT PADC
  • 17. 16 0 10 20 30 40 50 60 70 Alive Without Evidence of Disease Died of Disease Lost to Follow Up Overall Patient Outcomes Outcomes 1 Relapse 63 AWD 6 DOD 4 LTFU 58% 15% 14% 8% 5% Overall Type Distribution SPT PB PNT PADC Others SPT=42 PB=11 PNT=10 PADC=6 Others=4 Overall Results
  • 18. Overall Conclusions -Four main types of pancreatic tumors in children: pancreatoblastoma, solid pseudopapillary tumor, pancreatic neuroendocrine tumor, pancreatic ductal adenocarcinoma -Overall prognosis is much better, with 86% survival rate in our project, compared to adults with a 1-10% survival rate -Surgical resection via PT or PDD provided curative treatment -Specific trends/clues can help determine the type and grade of pancreatic tumors 17
  • 19. Future Directions 18 -Portion of project not completed: -Analysis of KID national database from Healthcare Cost and Utilization Project -To continue the project, we could: -Collect more specific experiences from institutions worldwide to minimize bias of the representation of only certain tumor types/institutions -In the future, we hope to create a presentable database for surgery conventions
  • 20. Presented by: Sebastian Hurtado Mentor: Dr. Wendy Su, M.D. Pediatric Surgical Associates of East Bay Acknowledgements: A special thank you to . . . END -Wendy Su, M.D. -The Doris Duke Charitable Foundation -Ellen Fung, PhD RD CCD -Ward Hagar, M.D. -Elaine Cham, M.D. CHRCO Pathologist -CHORI Summer Student Program Faculty and Staff
  • 21. Answers to Possible Questions  Hypotheses for better prognosis in children than adults: -increased check-ups/visits in children, cancer caught at lower stage -risk factors from lifestyle choices in adults (i.e. smoking, alcohol consumption) vs. genetics -biology of the tumor for each age group (SPT vs. pancreatic adenocarcinoma): “better” and “worse” types -types of tumors are different -overall “youth factor”: younger and more intact immune system 20

Editor's Notes

  1. Download free templates from FPPT.com http://www.free-power-point-templates.com/